April 12, 2007 — Medtronic Inc. has announced the formation of Medtronic CardioVascular, a new, global business combining Medtronic's existing Vascular and Cardiac Surgery businesses.
The new CardioVascular business at Medtronic will bring together people, technology and worldwide operations focused on delivering products, treatments and therapies for coronary artery, vascular and structural heart disease. The new business will have combined revenues of approximately $1.9 billion (FY07) and will consist of four major divisions:
* Coronary and Peripheral - minimally invasive catheter and stent-based technologies for the treatment of atherosclerosis;
* Endovascular Innovations - stent grafts for the treatment of aortic abdominal and thoracic aneurysms;
* Structural Heart Disease - products for the treatment of heart valve disease and atrial fibrillation; and
* Revascularization and Surgical Therapies - open heart and coronary bypass grafting surgical products
The four core divisions will remain in their current locations but will leverage common business processes and specific functional infrastructure while expanding scientific knowledge and engineering capabilities to advance cardiovascular care.
For more information visit www.medtronic.com.